The Southern United States experiences the greatest burden of HIV infection, illness, and deaths of any U.S. region, and lags in providing quality HIV prevention and care to all its citizens. To address these issues, we have developed a case-based CME program that explores and analyzed the demographics, epidemiology, risk factors, and treatment needs of patients with HIV infection in this region of the US.
This program including the online video discussion and clinically applicable live program series is expected to increase clinician awareness of this various issues with HIV care in the Southern US and offer solutions for addressing barriers in such areas as HIV prevention, HIV testing, linkage to care, adherence, and continuation in care.
This activity is intended for physicians, physician assistants, advanced practice nurses, general practitioners and other health care professionals involved in the treatment and management of patients who have or are at risk of HIV infection.
Upon completion of the program, participants should be able to:
Release Date: April 17, 2018
Expiration Date: April 17, 2019
Estimated time to complete each Module: 30 - 45 minutes
Computer System Requirements: Internet Connection and Browser
Roberto C. Arduino, MD
Professor of Medicine
UT Director of Research
Thomas Street Clinic
The University of Texas-Houston
Houston, Texas
Richard A. Elion, MD
Associate Professor of Clinical Medicine
George Washington University Medical Center
Washington, DC
Helena Kwakwa, MD, MPH
Director HIV Clinical Services
Philadelphia Department of Public Health
Ambulatory Health Services
Philadelphia, Pennsylvania
David Malebranche, MD
Associate Professor of Medicine
Morehouse School of Medicine
Atlanta, Georgia
David A. Wohl, MD
Professor
Division of Infectious Diseases
The University of North Carolina at Chapel Hill
Chapel Hill, North Carolina
 |
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and ViralEd, Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Module 1 (HIV-Positive, Middle Aged Female with Difficulty Continuing Care):
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Module 2 (HIV-Negative, High-risk Male, Interested in PrEP:
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Module 3 (HIV-Positive, Transgender Female):
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Module 4 (HIV-Positive, Undocumented Hispanic Male with Advancing AIDS):
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Module 5 (HIV-Positive, Middle-Aged Male, Long-standing Disease and Stigma Issues):
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Roberto C. Arduino, MD:
|
Richard A. Elion, MD:
|
Helena Kwakwa, MD:
|
David Malebranche, MD:
|
David Wohl, MD:
|
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
The PIM planners and managers have nothing to disclose.
There are no fees for participating and receiving CME/CE credit for this activity. During the period, April 17, 2018 through April 17, 2019, participants must read the learning objectives and faculty disclosures and study the educational activity.
If you wish to receive acknowledgment for completing this activity, please complete the evaluation on http://www.cmeuniversity.com/. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID 13230. Upon registering and successfully completing the activity evaluation, your certificate will be made available immediately.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This activity is supported by an independent educational grant from Gilead Sciences Medical Affairs
Jointly provided by the Postgraduate Institute for Medicine and ViralEd, Inc.
